These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

632 related articles for article (PubMed ID: 26539989)

  • 1. Intestinal Dysbiosis and Lowered Serum Lipopolysaccharide-Binding Protein in Parkinson's Disease.
    Hasegawa S; Goto S; Tsuji H; Okuno T; Asahara T; Nomoto K; Shibata A; Fujisawa Y; Minato T; Okamoto A; Ohno K; Hirayama M
    PLoS One; 2015; 10(11):e0142164. PubMed ID: 26539989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colonic bacterial composition in Parkinson's disease.
    Keshavarzian A; Green SJ; Engen PA; Voigt RM; Naqib A; Forsyth CB; Mutlu E; Shannon KM
    Mov Disord; 2015 Sep; 30(10):1351-60. PubMed ID: 26179554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson's disease.
    Forsyth CB; Shannon KM; Kordower JH; Voigt RM; Shaikh M; Jaglin JA; Estes JD; Dodiya HB; Keshavarzian A
    PLoS One; 2011; 6(12):e28032. PubMed ID: 22145021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease.
    Takahashi K; Nishida A; Fujimoto T; Fujii M; Shioya M; Imaeda H; Inatomi O; Bamba S; Sugimoto M; Andoh A
    Digestion; 2016; 93(1):59-65. PubMed ID: 26789999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of hydrogen production by intestinal bacteria that are specifically dysregulated in Parkinson's disease.
    Suzuki A; Ito M; Hamaguchi T; Mori H; Takeda Y; Baba R; Watanabe T; Kurokawa K; Asakawa S; Hirayama M; Ohno K
    PLoS One; 2018; 13(12):e0208313. PubMed ID: 30586410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural changes of gut microbiota in Parkinson's disease and its correlation with clinical features.
    Li W; Wu X; Hu X; Wang T; Liang S; Duan Y; Jin F; Qin B
    Sci China Life Sci; 2017 Nov; 60(11):1223-1233. PubMed ID: 28536926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysbiosis and zonulin upregulation alter gut epithelial and vascular barriers in patients with ankylosing spondylitis.
    Ciccia F; Guggino G; Rizzo A; Alessandro R; Luchetti MM; Milling S; Saieva L; Cypers H; Stampone T; Di Benedetto P; Gabrielli A; Fasano A; Elewaut D; Triolo G
    Ann Rheum Dis; 2017 Jun; 76(6):1123-1132. PubMed ID: 28069576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased urinary indoxyl sulfate (indican): new insights into gut dysbiosis in Parkinson's disease.
    Cassani E; Barichella M; Cancello R; Cavanna F; Iorio L; Cereda E; Bolliri C; Zampella Maria P; Bianchi F; Cestaro B; Pezzoli G
    Parkinsonism Relat Disord; 2015 Apr; 21(4):389-93. PubMed ID: 25707302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal Microbiota in Patients with Irritable Bowel Syndrome Compared with Healthy Controls Using Real-Time Polymerase Chain Reaction: An Evidence of Dysbiosis.
    Shukla R; Ghoshal U; Dhole TN; Ghoshal UC
    Dig Dis Sci; 2015 Oct; 60(10):2953-62. PubMed ID: 25784074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fecal markers of intestinal inflammation and intestinal permeability are elevated in Parkinson's disease.
    Schwiertz A; Spiegel J; Dillmann U; Grundmann D; Bürmann J; Faßbender K; Schäfer KH; Unger MM
    Parkinsonism Relat Disord; 2018 May; 50():104-107. PubMed ID: 29454662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-throughput 16S rRNA gene sequencing reveals alterations of intestinal microbiota in myalgic encephalomyelitis/chronic fatigue syndrome patients.
    Frémont M; Coomans D; Massart S; De Meirleir K
    Anaerobe; 2013 Aug; 22():50-6. PubMed ID: 23791918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partners of patients with ulcerative colitis exhibit a biologically relevant dysbiosis in fecal microbial metacommunities.
    Chen GL; Zhang Y; Wang WY; Ji XL; Meng F; Xu PS; Yang NM; Ye FQ; Bo XC
    World J Gastroenterol; 2017 Jul; 23(25):4624-4631. PubMed ID: 28740351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imbalance in intestinal microflora constitution could be involved in the pathogenesis of inflammatory bowel disease.
    Takaishi H; Matsuki T; Nakazawa A; Takada T; Kado S; Asahara T; Kamada N; Sakuraba A; Yajima T; Higuchi H; Inoue N; Ogata H; Iwao Y; Nomoto K; Tanaka R; Hibi T
    Int J Med Microbiol; 2008 Jul; 298(5-6):463-72. PubMed ID: 17897884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute dextran sulfate sodium (DSS)-induced colitis promotes gut microbial dysbiosis in mice.
    Munyaka PM; Rabbi MF; Khafipour E; Ghia JE
    J Basic Microbiol; 2016 Sep; 56(9):986-98. PubMed ID: 27112251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome.
    Duboc H; Rainteau D; Rajca S; Humbert L; Farabos D; Maubert M; Grondin V; Jouet P; Bouhassira D; Seksik P; Sokol H; Coffin B; Sabaté JM
    Neurogastroenterol Motil; 2012 Jun; 24(6):513-20, e246-7. PubMed ID: 22356587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysbiosis of the Duodenal Mucosal Microbiota Is Associated With Increased Small Intestinal Permeability in Chronic Liver Disease.
    Raj AS; Shanahan ER; Tran CD; Bhat P; Fletcher LM; Vesey DA; Morrison M; Holtmann G; Macdonald GA
    Clin Transl Gastroenterol; 2019 Aug; 10(8):e00068. PubMed ID: 31373933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Potential Role of Gut-Derived Inflammation in Multiple System Atrophy.
    Engen PA; Dodiya HB; Naqib A; Forsyth CB; Green SJ; Voigt RM; Kordower JH; Mutlu EA; Shannon KM; Keshavarzian A
    J Parkinsons Dis; 2017; 7(2):331-346. PubMed ID: 28234259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in fecal and colonic mucosal microbiota of patients with refractory constipation after a subtotal colectomy.
    Feng X; Su Y; Jiang J; Li N; Ding W; Wang Z; Hu X; Zhu W; Li J
    Am Surg; 2015 Feb; 81(2):198-206. PubMed ID: 25642885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Pilot Microbiota Study in Parkinson's Disease Patients versus Control Subjects, and Effects of FTY720 and FTY720-Mitoxy Therapies in Parkinsonian and Multiple System Atrophy Mouse Models.
    Vidal-Martinez G; Chin B; Camarillo C; Herrera GV; Yang B; Sarosiek I; Perez RG
    J Parkinsons Dis; 2020; 10(1):185-192. PubMed ID: 31561385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of Gut Microbiota in Patients with Parkinson's Disease.
    Petrov VA; Saltykova IV; Zhukova IA; Alifirova VM; Zhukova NG; Dorofeeva YB; Tyakht AV; Kovarsky BA; Alekseev DG; Kostryukova ES; Mironova YS; Izhboldina OP; Nikitina MA; Perevozchikova TV; Fait EA; Babenko VV; Vakhitova MT; Govorun VM; Sazonov AE
    Bull Exp Biol Med; 2017 Apr; 162(6):734-737. PubMed ID: 28429209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.